Colleges and teaching hospitals are the cornerstones of the city’s economy — and identity. But federal funding cuts to higher ...

For residents of Summerlin, the master-planned community’s active, outdoor lifestyle and beautiful natural surroundings are ...

Listed 4iG group and space engineering company REMRED topped out a space technology manufacturing centre in Martonvásár, on ...

Updates on the Eye-light device, Dibble Optical adds a trial frame to its portfolio, and bespoke is king in eyewear and ...

The AI model market is growing quickly, with companies like Google, Meta, and OpenAI leading the way in developing new AI ...

Despite a $400 million impairment charge, analysts say the removal of a drug-device combo from its portfolio is not a huge ...

Vertex halts VX-264 trials after missing efficacy goals but continues advancing zimislecel, a potential treatment for severe ...

In a report released today, William Pickering from Bernstein maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report), with ...

In a report released yesterday, Liisa Bayko from Evercore ISI maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report), with ...

We recently published a list of 8 Best Gene-Editing Stocks to Buy. In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against other best ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...